Manulife (Manufacturers Life Insurance)
ORMP icon

Manulife (Manufacturers Life Insurance)’s Oramed Pharmaceuticals ORMP Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,777
Closed -$128K – 3100
2022
Q1 		$128K Sell
14,777
-1,262
-8% -$12.9K ﹤0.01% 2917
2021
Q4 		$229 Sell
16,039
-144
-0.9% -$3.01K ﹤0.01% 2813
2021
Q3 		$356K Buy
16,183
+234
+1% +$3.98K ﹤0.01% 2543
2021
Q2 		$213K Buy
+15,949
New +$182K ﹤0.01% 3064

Other funds holding ORMP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ORMP Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Oramed Pharmaceuticals (ORMP) in Q2 2022, closing a stake of 14,777 shares — an estimated $128K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ORMP in Q2 2021 and held it in 4 quarters. The position peaked at $356K in Q3 2021. 88 funds tracked by Wall St. Rank hold ORMP as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Oramed Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 14,777 Oramed Pharmaceuticals shares in Q2 2022, an estimated $128K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Oramed Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • Manulife (Manufacturers Life Insurance)'s Oramed Pharmaceuticals position peaked at $356K in Q3 2021.
  • 88 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.